ClinicalTrials.gg
CompletedNCT06574841Updated Oct 30, 2026

Effect of Blood Flow Restriction on Pain Perception, Grip Strength and Nerve Conductivity in CTS Patients.

An interventional study of Blood Flow Restriction training in Carpal Tunnel Syndrome and Blood Flow Restriction (BFR) Training Effects, sponsored by Ahmed ElMelhat. Completed at 1 site in Egypt. Open to female participants aged 30 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-10-30.

Sponsored by Ahmed ElMelhat · Not applicable, Interventional, and Treatment

How we know

Updated Oct 30, 2026Now CompletedStart date moved+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Randomized
Ages
30 Years to 55 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 64 studies in Carpal Tunnel Syndrome with a site in Egypt — 20 open to participants now, 22 under way, 1 of them phase 3. Carpal Tunnel Syndrome · Egypt.

Enrollment
35th of 53
54 · median 60
Started
2024
with 4 others
No phase
44 of 64
12 open now
Registered
46th of 64
by date
Lead sponsor
1 of 64
Ahmed ElMelhat

Among the 64 studies in Carpal Tunnel Syndrome with a site in Egypt, this one is the 35th largest by enrollment of the 53 interventional ones that give a count, is one of 5 that started in 2024, is one of 44 with no phase, and was the 46th registered.

Carpal Tunnel Syndrome

591 studies on the registry are indexed under Carpal Tunnel Syndrome; 133 are open to participants now.

Browse Carpal Tunnel Syndrome studies →

Open to participants now

20 of the 64 studies in Carpal Tunnel Syndrome with a site in Egypt are open now. Recruiting first, the newest first:

15 more — sign in →

All 20 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 72 Carpal Tunnel Syndrome studies recruiting now, 27 (38%) set no upper age limit and 36 (50%) stop at 75 or younger; 1 takes children under 18; 11 take healthy volunteers.

This study: 30 Years to 55 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 64 studies in Carpal Tunnel Syndrome with a site in Egypt, or all of them as a file.
02

Study summary

The goal of this clinical trial is to investigate the effect of blood flow restriction (BFR) on pain perception, grip strength and nerve conductivity in patients suffering from carpal tunnel syndrome (CTS). The main question it aims to answer is:

Does performing blood flow restriction training decrease pain, improve grip strength and does not alter nerve conduction velocity in patients with (CTS)? The participants will be divided into two groups to be compared: Patients in the control group will receive the conventional physical therapy program only. In contrast, participants in the experimental group will receive blood flow restriction (BFR) training in addition to a conventional physical therapy program (which includes an orthotic device, tendon, and nerve-gliding exercises).

Read the detailed description

Blood flow restriction (BFR) entails a training technique that partially limits arterial blood flow and completely restricts venous blood outflow within the active musculature during physical activity. By restricting the outflow of blood from the limb, the resulting lack of oxygen creates conditions that stimulate muscle growth through cellular signaling and hormonal changes, resembling the effects of higher-intensity training with increased resistance. Emerging studies indicate that Exercise-induced hypoalgesia (EIH) delineates a transient decrease in pain sensitivity subsequent to physical activity. Moreover, research indicates that individuals diagnosed with carpal tunnel syndrome (CTS) typically exhibit reduced grip strength Furthermore, acute application of submaximal blood flow restriction (BFR) for approximately 5 minutes does not influence the magnitude or timing of H wave responses.

Thus, the investigators hypothesized that performing blood flow restriction training will decrease pain, improve grip strength and does not alter the nerve conduction velocity in patients with carpal tunnel syndrome (CTS).

03

Conditions studied

  • Carpal Tunnel Syndrome
  • Blood Flow Restriction (BFR) Training Effects

Keywords

  • Carpal Tunnel Syndrome, Blood Flow Restriction.
04

Who can participate

Ages eligible
30 Years to 55 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. patients diagnosed by a physician according to the American Academy of Orthopedic Surgeon with carpal tunnel syndrome (CTS).
  2. age:30-55 years old.
  3. females.
  4. positive clinical provocative tests for CTS (Tinel test and Phalen test).
  5. subjects with a history of paresthesia, numbness, or pain in the median nerve distribution, night waking, and nocturnal pain.

Exclusion criteria

Exclusion Criteria:

  1. subjects who had carpal tunnel release surgery.
  2. subjects with cervical disc prolapse.
  3. subjects with cervical spondylosis.
  4. subjects with thoracic outlet syndrome (TOS).
  5. subjects with diabetes.
  6. subjects with gestational diabetes.
  7. subjects with cardiovascular disorders.
  8. subjects with hypertension.
  9. pregnant women.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
54 participants (actual)

Study arms

  • Active comparator
    Blood Flow Restriction Training

    Blood flow restriction resistance exercise (BFR-RE) involves partially restricting arterial blood flow and fully restricting venous blood flow in the active limb during exercise, utilizing loads typically set at 20% to 30% of an individual's maximum repetition (1RM). It will conduct 3-5 sets until concentric failure is achieved, each set will contain 15-30 repetitions. Moreover, rest periods will range from 30 to 60 seconds and 3 sessions per week will be performed.

    Other: Blood Flow Restriction training

  • Experimental
    Conventional Physical therapy

    It consists of the application of a neural custom volar orthotic device to be worn at night and during strenuous daytime activities. Moreover,exercises required patients to assume five different finger postures during tendon-gliding activities: Straight, Hook Fist, Duck Position, Straight Fist, and Full Fist. As well as, six different postures during nerve-gliding activites: Wrist positioned neutrally with flexed thumb and fingers, Wrist maintained neutrally with extended thumb and fingers, Extended wrist and fingers with the thumb in a neutral position, Extended wrist, fingers, and thumb, Extended wrist, fingers, and thumb with forearm supination, and Extended wrist, fingers, and thumb with forearm supination, accompanied by gentle stretching of the thumb by the therapist. All will be done 10rep x 5 sec hold, 3-5 times daily for 5 weeks.

    Other: Blood Flow Restriction training

Interventions

  • OtherBlood Flow Restriction training

    BFR training done 3 sessions per week, each session includes low intensity of 20% to 30% of 1RM, 3 sets of 15 to 30 reps with a 30sec resting period done for 6 weeks.Moreover, nerve and tendon-gliding exercises consists of 10 reps with a 5-second hold, 3-5 times done daily for 5 weeks.

    Also known as: Nerve and tendon-gliding exercises with a customized volar orthotic device

06

What researchers measure

Primary outcomes

  1. Electromyography to evaluate median nerve abnormalities specifically within the wrist, assessing their severity, and ruling out other conditions that may imitate carpal tunnel syndrome.

    EMG activity for motor and sensory nerve conduction: 1. Electrode used for motor median nerve conduction positioned over the abductor pollicis brevis. 2. Electrode used for sensory median nerve conduction positioned 2cm distally for the thumb, the index, middle, and ring finger.

    Time frame: Baseline and after 6 weeks

Secondary outcomes

  1. Grip Strength

    The JAMAR Hydraulic Hand Dynamometer, frequently utilized in research investigations, holds a powerful validation and is esteemed as the gold standard against which the efficacy of other devices is measured.

    Time frame: Baseline and after 6 weeks

  2. Numerical pain rating scale

    The numeric rating scale (NRS) is a widely utilized pain screening tool for assessing the severity of pain at a given moment, utilizing a scale from 0 to 10. Zero denotes the absence of pain, while 10 signifies the highest imaginable pain intensity.

    Time frame: Baseline and after 6 weeks

07

Study locations

1 site
  • Ahmed ElMelhat [aelmelhat]
    Cairo, Egypt
08

References and documents

Publications

  • Patterson SD, Hughes L, Warmington S, Burr J, Scott BR, Owens J, Abe T, Nielsen JL, Libardi CA, Laurentino G, Neto GR, Brandner C, Martin-Hernandez J, Loenneke J. Blood Flow Restriction Exercise: Considerations of Methodology, Application, and Safety. Front Physiol. 2019 May 15;10:533. doi: 10.3389/fphys.2019.00533. eCollection 2019. PubMed 31156448 ↗
  • Wortman RJ, Brown SM, Savage-Elliott I, Finley ZJ, Mulcahey MK. Blood Flow Restriction Training for Athletes: A Systematic Review. Am J Sports Med. 2021 Jun;49(7):1938-1944. doi: 10.1177/0363546520964454. Epub 2020 Nov 16. PubMed 33196300 ↗
  • Hughes L, Patterson SD. The effect of blood flow restriction exercise on exercise-induced hypoalgesia and endogenous opioid and endocannabinoid mechanisms of pain modulation. J Appl Physiol (1985). 2020 Apr 1;128(4):914-924. doi: 10.1152/japplphysiol.00768.2019. Epub 2020 Feb 27. PubMed 32105522 ↗
  • Sasaki T, Makino K, Nimura A, Suzuki S, Kuroiwa T, Koyama T, Okawa A, Terada H, Fujita K. Assessment of grip-motion characteristics in carpal tunnel syndrome patients using a novel finger grip dynamometer system. J Orthop Surg Res. 2020 Jul 6;15(1):245. doi: 10.1186/s13018-020-01773-9. PubMed 32631378 ↗
  • Mendonca GV, Mouro M, Vila-Cha C, Pezarat-Correia P. Nerve conduction during acute blood-flow restriction with and without low-intensity exercise Nerve conduction and blood-flow restriction. Sci Rep. 2020 Apr 30;10(1):7380. doi: 10.1038/s41598-020-64379-5. PubMed 32355236 ↗
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2024 to primary completion in Jun 2025, 8 months.

Of 252 non-industry interventional studies with no phase under Carpal Tunnel Syndrome, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 27. This study's 8 months is below that.

Counting every sponsor, half of 262 studies reached it within 12 months; a quarter within 7 and three quarters within 26.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 30, 2026: start May 2024 → Oct 2024, primary completion Dec 2024 → Jun 2025 and completion Jan 2025 → Jun 2025.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 26, 2024
First posted
Aug 28, 2024
StartActual
Oct 1, 2024was May 2024
Primary completionActual
Jun 18, 2025was Dec 2024
CompletionActual
Jun 20, 2025was Jan 2025
Last update
Oct 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 30, 2026
Start date
May 7, 2024→Oct 1, 2024
Oct 30, 2026
Primary completion
Dec 18, 2024→Jun 18, 2025 (actual)
Oct 30, 2026
Study completion
Jan 27, 2025→Jun 20, 2025 (actual)
Oct 30, 2026
Enrollment
30 (estimated)→54 (actual)
Oct 30, 2026
Sponsor
Cairo University→Ahmed ElMelhat
Oct 30, 2026
Show all 1 update
  1. Oct 30, 2026
    Recruiting→Completed
    Start date May 7, 2024→Oct 1, 2024
    Primary completion Dec 18, 2024→Jun 18, 2025 (now actual)
    Study completion Jan 27, 2025→Jun 20, 2025 (now actual)
    Enrollment 30 (estimated)→54 (actual)
    Sponsor Cairo University→Ahmed ElMelhat
    + 7 other changes: verification date, description, conditions, contact details, site details, references and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06574841
Lead sponsor
Ahmed ElMelhat
Responsible party
Ahmed ElMelhat (Effect of BFR on Pain perception,Grip Strength and Nerve conductivity in CTS patients, Cairo University) — Sponsor-investigator
First posted
Aug 28, 2024
Start date
Oct 1, 2024
Primary completion
Jun 18, 2025
Completion
Jun 20, 2025
Last update
Oct 30, 2026

Study contacts

Ahmed M El Melhat, Phd
study director · Cairo University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion